» Articles » PMID: 17890332

Differences in Virulence Among Escherichia Coli O157:H7 Strains Isolated from Humans During Disease Outbreaks and from Healthy Cattle

Overview
Date 2007 Sep 25
PMID 17890332
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Escherichia coli O157:H7 causes life-threatening outbreaks of diarrhea, hemorrhagic colitis, and hemolytic-uremic syndrome in humans and significant economic loss in agriculture and could be a potential agent of bioterrorism. Although the prevalence of E. coli O157:H7 in cattle and other species with which humans have frequent contact is high, human infections are relatively uncommon, despite a low infectious dose. A plausible explanation for the low disease incidence is the possibility that not all strains are virulent in humans. If there are substantial differences in virulence among strains in nature, then human disease may select for high virulence. We used a gnotobiotic piglet model to investigate the virulence of isolates from healthy cattle and from humans in disease outbreaks and to determine the correlation between production of Shiga toxin 1 (Stx1) and Stx2 and virulence. Overall, E. coli O157:H7 strains isolated from healthy cattle were less virulent in gnotobiotic piglets than strains isolated from humans during disease outbreaks. The amount of Stx2 produced by E. coli O157:H7 strains correlated with strain virulence as measured by a reduction in piglet survival and signs of central nervous system disease due to brain infarction. The amount of Stx1 produced in culture was not correlated with the length of time of piglet survival or with signs of central nervous system disease. We suggest that disease outbreaks select for producers of high levels of Stx2 among E. coli O157:H7 strains shed by animals and further suggest that Stx1 expression is unlikely to be significant in human outbreaks.

Citing Articles

Pathogenomes and variations in Shiga toxin production among geographically distinct clones of O113:H21.

Allue-Guardia A, Koenig S, Martinez R, Rodriguez A, Bosilevac J, Feng P Microb Genom. 2022; 8(4).

PMID: 35394418 PMC: 9453080. DOI: 10.1099/mgen.0.000796.


Intimate Attachment of O157:H7 to Urinary Bladder Epithelium in the Gnotobiotic Piglet Model.

Moxley R, Bargar T, Kachman S, Baker D, Francis D Microorganisms. 2020; 8(2).

PMID: 32075320 PMC: 7074727. DOI: 10.3390/microorganisms8020263.


Toxigenic properties and stx phage characterization of Escherichia coli O157 isolated from animal sources in a developing country setting.

Rahman M, Nabi A, Asadulghani M, Faruque S, Islam M BMC Microbiol. 2018; 18(1):98.

PMID: 30170562 PMC: 6119239. DOI: 10.1186/s12866-018-1235-3.


Efficacy of Urtoxazumab (TMA-15 Humanized Monoclonal Antibody Specific for Shiga Toxin 2) Against Post-Diarrheal Neurological Sequelae Caused by Escherichia coli O157:H7 Infection in the Neonatal Gnotobiotic Piglet Model.

Moxley R, Francis D, Tamura M, Marx D, Santiago-Mateo K, Zhao M Toxins (Basel). 2017; 9(2).

PMID: 28134751 PMC: 5331429. DOI: 10.3390/toxins9020049.


The Shiga toxin 2 production level in enterohemorrhagic Escherichia coli O157:H7 is correlated with the subtypes of toxin-encoding phage.

Ogura Y, Mondal S, Islam M, Mako T, Arisawa K, Katsura K Sci Rep. 2015; 5:16663.

PMID: 26567959 PMC: 4645166. DOI: 10.1038/srep16663.


References
1.
Tarr P, Gordon C, Chandler W . Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet. 2005; 365(9464):1073-86. DOI: 10.1016/S0140-6736(05)71144-2. View

2.
Keenan K, Sharpnack D, Collins H, Formal S, OBrien A . Morphologic evaluation of the effects of Shiga toxin and E coli Shiga-like toxin on the rabbit intestine. Am J Pathol. 1986; 125(1):69-80. PMC: 1888447. View

3.
Obrig T, Moran T, Brown J . The mode of action of Shiga toxin on peptide elongation of eukaryotic protein synthesis. Biochem J. 1987; 244(2):287-94. PMC: 1147989. DOI: 10.1042/bj2440287. View

4.
Tzipori S, Wachsmuth K, Smithers J, Jackson C . Studies in gnotobiotic piglets on non-O157:H7 Escherichia coli serotypes isolated from patients with hemorrhagic colitis. Gastroenterology. 1988; 94(3):590-7. DOI: 10.1016/0016-5085(88)90228-4. View

5.
McNally A, Roe A, Simpson S, Thomson-Carter F, Hoey D, Currie C . Differences in levels of secreted locus of enterocyte effacement proteins between human disease-associated and bovine Escherichia coli O157. Infect Immun. 2005; 73(4):2571. PMC: 1087469. DOI: 10.1128/IAI.73.4.2571.2005. View